Mr Ross Rezaei, OTR/L, HTC in Irvine, CA - Medicare Occupational Therapy Provider

Mr Ross Rezaei, OTR/L, HTC is a medicare enrolled "Occupational Therapist - Hand" provider in Irvine, California. He graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Occupational Therapy. He is a member of the group practice Advance Occupational And Hand Therapy Center and his current practice location is 22 Odyssey, Suite 165, Irvine, California. You can reach out to his office (for appointments etc.) via phone at (949) 727-2192.

Mr Ross Rezaei is licensed to practice in California (license number OT1251) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1033130679.

Contact Information

	Mr Ross Rezaei, OTR/L, HTC
	22 Odyssey, Suite 165, Irvine, CA 92618-3186
	(949) 727-2192
	(949) 727-2193

Healthcare Provider's Profile

Full Name	Mr Ross Rezaei
Gender	Male
Speciality	Occupational Therapy
Experience	26 Years
Location	22 Odyssey, Irvine, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mr Ross Rezaei graduated from medical school in 1998

NPI Data:

NPI Number: 1033130679
Provider Enumeration Date: 07/21/2006
Last Update Date: 04/13/2020

Medicare PECOS Information:

PECOS PAC ID: 0446215826
Enrollment ID: I20041124000582

Medical Identifiers

Medical identifiers for Mr Ross Rezaei such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033130679	NPI	-	NPPES
3791439	Medicaid	CA
OT0012510	Other	CA	BLUE SHIELD OF CALIFORNIA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XH1200X	Occupational Therapist - Hand	OT1251 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Advance Occupational And Hand Therapy Center	0143251579	7

News Archive

Changing placebo response dilutes antipsychotic trial power

Factors including patients' expectations may underlie an increased placebo response in antipsychotic randomised controlled trials published since 1960, say researchers.

Biofortuna achieves key milestones in development of new blood group genotyping product family

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has successfully achieved key milestones in the development of its new blood group genotyping product family – ReadyPlex™.

All claims brought against Medical Properties Trust and other entities rejected

Medical Properties Trust, Inc. announced today that a State District Court jury in Harris County, Texas rejected all claims brought against the company and other entities by a group of physicians whose efforts to create and operate a new hospital in Houston failed in 2006.

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing.

Proposed Federal budget cuts will put seniors at risk

The Health Facilities Association of Maryland (HFAM) today brought together U.S. Representative Frank Kratovil (MD-1) and residents, workers and leaders from the Salisbury Rehabilitation and Nursing Center to personalize the pending effects of a proposed $32 billion federal cut to Medicare.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Ross Rezaei allows following entities to bill medicare on his behalf.

Provider Name	Advance Occupational & Hand Therapy Center
Provider Type	Part B Supplier - Physical/occupational Therapy Group In Private Practice
Provider Identifiers	NPI Number: 1093746752 PECOS PAC ID: 0143251579 Enrollment ID: O20050830001031

News Archive

Changing placebo response dilutes antipsychotic trial power

Factors including patients' expectations may underlie an increased placebo response in antipsychotic randomised controlled trials published since 1960, say researchers.

Biofortuna achieves key milestones in development of new blood group genotyping product family

All claims brought against Medical Properties Trust and other entities rejected

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Proposed Federal budget cuts will put seniors at risk

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Ross Rezaei is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Ross Rezaei, OTR/L, HTC 22 Odyssey Ste 165, Irvine, CA 92618-3194 Ph: (949) 727-2192	Mr Ross Rezaei, OTR/L, HTC 22 Odyssey, Suite 165, Irvine, CA 92618-3186 Ph: (949) 727-2192

News Archive

Changing placebo response dilutes antipsychotic trial power

Factors including patients' expectations may underlie an increased placebo response in antipsychotic randomised controlled trials published since 1960, say researchers.

Biofortuna achieves key milestones in development of new blood group genotyping product family

All claims brought against Medical Properties Trust and other entities rejected

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Proposed Federal budget cuts will put seniors at risk

Occupational Therapist in Irvine, CA

Adee Rozov, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18881 Von Karman Ave Ste 1240, Irvine, CA 92612 Phone: 949-885-0300
Irvine Therapy Services, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16631 Noyes Ave, Irvine, CA 92606 Phone: 949-252-9946 Fax: 949-559-4366
Tamara Mangum, B.S. OCCUPATIONAL TH Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1663 Noyes Ave, Irvine, CA 92606 Phone: 949-252-9946
Mary Elizabeth Bremer, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16269 Laguna Canyon Rd, Irvine, CA 92618 Phone: 949-788-9236 Fax: 949-788-9246
Alistair Alaba Agujar, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 52 Distant Star, Irvine, CA 92618 Phone: 949-468-7322
Jordyn Elizabeth Halterman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17861 Von Karman Ave, Irvine, CA 92614 Phone: 949-222-2214

Mr Ross Rezaei, OTR/L, HTC - Medicare Occupational Therapist in Irvine, CA

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Changing placebo response dilutes antipsychotic trial power

Biofortuna achieves key milestones in development of new blood group genotyping product family

All claims brought against Medical Properties Trust and other entities rejected

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Proposed Federal budget cuts will put seniors at risk

Medicare Reassignments

Changing placebo response dilutes antipsychotic trial power

Biofortuna achieves key milestones in development of new blood group genotyping product family

All claims brought against Medical Properties Trust and other entities rejected

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Proposed Federal budget cuts will put seniors at risk

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Changing placebo response dilutes antipsychotic trial power

Biofortuna achieves key milestones in development of new blood group genotyping product family

All claims brought against Medical Properties Trust and other entities rejected

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Proposed Federal budget cuts will put seniors at risk

Occupational Therapist in Irvine, CA